Clinical Trials in Colorado

Showing 10901-10920 of 15,592 trials

Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease

NCT02013791

This study will evaluate a new ophthalmic formulation of cyclosporine (Restasis® X) in patients with moderate to severe dry eye disease in two stages. Up to 3 doses will be studied in Stage 2 based on results from Stage 1. No patients participating in Stage 1 will participate in Stage 2 of this study. This study was terminated and Stage 2 of the study was cancelled.

Dry Eye Syndromes

Allergan55 participantsStarted Apr 2014

Artesia, California, United States • Glendale, California, United States • Irvine, California, United States +5 more locations

TERMINATEDPhase 331 miles

A Study in Participants With Rheumatoid Arthritis

NCT01202773

The primary purpose of this study is to help answer if LY2127399 is safe and effective in the treatment of rheumatoid arthritis in participants with an inadequate response to one or more tumor necrosis factor-alpha (TNF-α) inhibitors. This study is comprised of 2 periods: Period 1: 24-week blinded treatment Period 2: 48-week post-treatment follow-up

Rheumatoid Arthritis

Eli Lilly and Company456 participantsStarted Jan 2011

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Paradise Valley, Arizona, United States +198 more locations

Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease

A Study in Participants With Rheumatoid Arthritis

Find Trials by Condition in Colorado

Phase 1 and 2 Study of PX-866 and Cetuximab

Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I

Phase I Trial of Oral PX-866

A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.

Phase 1 Study of ONT-10 in Patients With Solid Tumors

Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention Experiment

A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

PF-00489791 For The Treatment Of Raynaud's

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incisional Hernia Repair

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Radiosurgery or Open Surgery for Epilepsy Trial

Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis

Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers

Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer

The Impact of Vitamin D on Disease Activity in Crohn's Disease

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017